About 40% of drugs in the pipeline and 60% of drugs coming directly from synthesis or high throughput screening
are classified as poorly soluble. Consequently, they have bioavailability and/or delivery problems.
PharmaSol provides solutions for overcoming the solubility and related bioavailability problems of poorly soluble
compounds. PharmaSol solutions are simple, cost-effective, regulatorily acceptable and cover lab to industrial
scale production. Focus areas are oral, dermal and intravenous delivery.
Pharmaceutical solutions to increase the Solubility of poorly soluble compounds.
(C)opyright 2004, PharmaSol GmbH. All rights reserved.